Consumer Protection
53 open or forecast opportunities.
Rapid Response Team (RRT) Cooperative Agreement
The purpose of the NOFO is to facilitate long-term improvements and innovation to the national integrated food safety system by unifying and coordinating federal/state/local human and animal food (HAF) emergency response efforts including: 1) Strengthening the link among epidemiology, lab, and environmental ...
Data Standards for Tobacco Research and Scientific Review Phase 2
To support high-quality tobacco research, streamline scientific review, and evaluation, and ultimately, improve public health outcomes related to tobacco use, the Center for Tobacco Products (CTP) at the Food and Drug Administration (FDA) is welcoming applications for data standards and terminologies development ...
FY26 US DOT Drone Infrastructure Inspection Grants (DIIG) Program
The Drone Infrastructure Inspection Grants (DIIG) Program will provide grants to eligible government entities to facilitate the use of small Unmanned Aircraft Systems (UAS), referred to herein as drones, in critical infrastructure inspection. The objective is to increase the widespread adoption of drones and relevant ...
Minor Use Minor Species Development of Drugs (R01)
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for ...
State Process for Informing Consumers of Recalls Program
The objective of the State Process for Informing Consumers of Recalls Grant program is to establish a recall notification program in a state to improve traffic safety in the following areas: developing a methodology for determining open recalls on motor vehicles, informing owners and lessees of the open recalls at the ...
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
The purpose of this Notice of Funding Opportunity (NOFO) is to advance efforts for a nationally integrated animal food safety system providing state animal food regulatory programs the ability to achieve full implementation of the Animal Food Regulatory Program Standards (AFRPS) within 5 years and to maintain full ...
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic ...
Laboratory Flexible Funding Model (LFFM)
This cooperative agreement is intended to enhance the capacity and capabilities of state human and animal food testing laboratories in support of an integrated food safety system (IFSS). This is achieved through prioritized sample testing and food defense preparedness in the areas of microbiology, chemistry, and ...
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to ...
Animal and Veterinary Innovation Centers (U18)
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for inclusion as Animal and Veterinary Innovation Centers, which are intended to form long-term partnerships to address priority areas for FDA's Center for Veterinary Medicine (CVM). This includes CVM developing cooperative ...
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative ...
Vet-LIRN Capacity-Building Project and Equipment Grants (U18)
The goal of this NOFO is to fund veterinary diagnostic laboratories in the Vet-LIRN network for grants associated with projects and equipment. Specific objectives include: 1. Supporting the development, adaptation, or verification/validation of new methods associated with animal food issues or antimicrobial ...
Manufactured Foods Flexible Funding Model (MF-FFM)
The purpose of the NOFO is to advance efforts for a nationally integrated food safety system (IFSS) by supporting Manufactured Food Regulatory Program Standards (MFRPS), dietary supplement safety and oversight programs, improved state compliance and enforcement infrastructure, and state Food Protection Task Force ...
Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
Complex generic drug products represent an increasing share of the generic marketplace and may have distinct user interface differences compared to reference listed drug (RLD) products. A modernized post-market surveillance approach is needed to compare clinical outcomes between complex generic products and their ...
Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)
The purpose of this funding opportunity is to support the research and development necessary to advance non-invasive (e.g., quantitative tomography-based) technologies, including the development of apparatus, methods, study designs, and methods of data analysis, to characterize and compare the rate and extent to which ...
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
The purpose of this funding opportunity is to examine the utility of an in vitro simulated gastrointestinal (GI) dissolution model for the assessment of in vitro performance of amorphous solid dispersion (ASD) drug products under different clinically relevant conditions. The goal is to develop and validate the in ...
Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed
Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged period of time. Accidental exposure of these products to alcohol can result in the relatively rapid release of large ...
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to understand the biological/pharmacological activity of each diastereomer in LEQVIO through stereo chemically controlled ...
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement. The proposed work directly supports the U.S. FDA’s stated goal of protecting public health from unacceptable risks ...
Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed
The intended outcome of this Notice of Funding Opportunity (NOFO) is to advance efforts for a nationally Integrated Food Safety System (IFSS) by supporting Manufactured Food Regulatory Program Standards (MFRPS), Food Protection Task Force (FPTF) programs, Dietary Supplement (DS) programs, and special projects. For the ...
Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)
The U.S. Food and Drug Administration (FDA) seeks applications to develop, implement, and evaluate a human abuse potential (HAP) study of botanical Kratom. FDA has previously warned consumers about the use of Kratom (Mitragyna speciosa), a plant indigenous to Southeast Asia. Kratom alkaloids have demonstrated both ...
Critical Path Public Private Partnerships Clinical Trials Optional
The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 566 ...
Minor Use Minor Species Development of Drugs (R01)
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for ...
Collaborations to Enhance Drug Development and Regulatory Science
This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science efforts. FDA and grantees will work together to develop ...
Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
The purpose of this FOA is to develop and maintain Rapid Response Teams (RRTs) to facilitate long-term improvements and innovation to the national integrated food safety system by unifying and coordinating federal/state/local human and animal food (HAF) emergency response efforts including: 1) Strengthening the link ...
FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance minority health and health equity objectives. Areas of interest include: Proposals that focus on advancing equity in clinical trials by supporting efforts to advance diversity in clinical trials, ...
OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on potential risks from skin lightening products containing hydroquinone and/or mercury. Applicants will ...
Animal Food Regulatory Program Alliance
The goal of FDA/ORA's Cooperative Agreement Program is to facilitate long-term improvements to the national food safety system by strengthening interagency collaboration, improving States' regulatory and surveillance protection programs for manufactured foods, conducting research, and promotion of the Animal Food ...
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives
The purpose of this Notice of Funding Opportunity (NOFO) is to advance efforts for a nationally integrated animal food safety system providing State animal food regulatory programs the ability to achieve and maintain full implementation of the Animal Feed Regulatory Program Standards (AFRPS), and to fund optional ...
Center for Research on Complex Generics (U18) Clinical Trials Optional
The Food and Drug Administration (FDA) seeks to fund a Center for Research on Complex Generics under the terms and conditions of a cooperative agreement. The Center for Research on Complex Generics will support the FDA's efforts to enhance collaborations with the generic drug industry relating to generic drug ...
Integrated Food Safety System Regulatory and Laboratory Training System National Coordination Center
The Office of Partnerships (OP) would like to develop a Notice of Funding Opportunity (NOFO) to award a $1.5M cooperative agreement to a non-profit entity to serve as the Integrated Food Safety System (IFSS) Regulatory and Laboratory Training System (RLTS) National Coordination Center (NCC). The NCC will provide ...
Studies Addressing Rare Neurodegenerative Diseases including ALS
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to ...
Retail Food Safety Regulatory Association Collaboration CAP
The proposed cooperative agreement is a renewal of the existing CAP supporting key stakeholders in retail food safety to coordinate and advance retail food protection in the United States. The intended outcome of this NOFO is to collaboratively advance retail food safety initiatives to reduce food-borne illness. This ...
Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed
To develop, disseminate, implement, and evaluate research needed in Anesthesia, Addiction Medicine and Pain Medicine in various fields of research. Specifically, research is needed in the following fields: function as a clinical trial endpoint and measurement of function in patients with chronic pain, outcome measures ...
Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines
To support dissemination of clinical practice guidelines, particularly those whose development was previously supported by FDA cooperative agreements. Applicants must propose a comprehensive plan to develop, evaluate, and distribute materials to facilitate dissemination, with a focus on equity.
Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
The purpose of this notice of funding opportunity (NOFO) is to fund innovative research that will strengthen and advance minority health and health equity objectives. Areas of interest include: Proposals that focus on advancing equity in clinical trials by supporting efforts to advance diversity in clinical trials, ...
REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional
This purpose of this notice of funding opportunity (NOFO) is for FDA Office of Minority Health and Health Equity's (OMHHE) Health Equity Innovation Award: Racial & Ethnic Minority Acceleration Consortium for Health Equity (REACH). The consortium will consist of multiple cooperative agreement (U01) recipients that will ...
Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on the use of and potential risks from skin lightening products (e.g., hydroquinone). Applicants will ...
Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical trials, FDA expects to ...
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic ...
Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics
The goal of this funding opportunity announcement is to support applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics. The main outcomes of this work will be publications and presentations; however, FDA staff anticipate substantial involvement in study design and reviewing ...
Food Safety Capacity and Infrastructure Building (U2F)
The purpose of this funding opportunity is to support the development, support, and promotion of innovative information sharing and research tools hosted on the Integrated Food Safety System (IFSS) collaboration/research portal, which serves as a critical federal-state collaboration portal to advance food safety and ...
Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to ...
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
The purpose of this opportunity is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA ...
Conformance with the Egg Regulatory Program Standards
The purpose of this funding opportunity is to advance efforts for a nationally integrated food regulatory system by assisting state egg regulatory programs to achieve and maintain full conformance with the Egg Regulatory Program Standards (ERPS). The ERPS Cooperative Agreement will provide funding for state egg ...
FDA's Integrated Food Safety System Training Delivery and Development
The purpose of this funding opportunity is to support the advancement of a nationwide, Integrated Food Safety System (IFSS).
Federal and State Integration Activities to Advance Cooperation and Regulatory Standards Among Animal Food Safety Regulatory Programs
The purpose is to provide a funding opportunity for national feed associations to advance and promote a national animal food safety system by building inter-agency collaboration, improving states' regulatory and surveillance protection programs, and promoting the Animal Feed Regulatory Program Standards (AFRPS). ...
Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities
The goals of this grant are to better understand the landscape of drug shortage products, including those vulnerable to health fraud, and identify opportunities for outsourcing facilities to meet drug shortage needs to strengthen the supply chain. Funding would also support outsourcing facilities’ research and ...
Retail Food Safety Regulatory Association Collaboration
The program furthers the FDA's support of state, local, tribal, and territorial (SLTT) retail food safety programs in their efforts to reduce the occurrence of food-borne illness risk factors for the benefit of the public. Recipients of this funding will assist SLTT agencies in conducting research, implementing ...
Novel approaches to support therapeutic development in ultra-rare cancers
The purpose of this program is to support new approaches that can be applied to facilitate therapeutic development in ultra-rare pediatric and adult cancers, including molecularly-defined subsets of more common cancers. Specific areas of interest include, but are not limited to, the following examples: • Development ...
Development and Maintenance of Human and Animal Food Rapid Response Teams
The purpose of this Notice of Funding Opportunity (NOFO) is to develop and maintain Rapid Response Teams (RRTs) to facilitate long-term improvements and innovation within the national integrated food safety system by unifying and coordinating federal, state, and local human and animal food (HAF) emergency response ...
National Produce Safety Partnership Program
This funding opportunity aims to improve the safety of fresh produce and prevent produce-related illnesses.
Flexible Funding Model - Advancing Domestic Mutual Reliance Through Strengthened Infrastructure Development and Maintenance for Manufactured Food Regulatory Programs
The purpose of this Notice of Funding Opportunity (NOFO) is to advance manufactured food regulatory program infrastructure capacity and capability to achieve and maintain conformance with the Manufactured Food Regulatory Program Standards (MFRPS) and advance mutual reliance in food safety. The primary objectives will ...